Breast Cancer

The following activities are available for studies related to the biology, diagnosis, screening, prevention, and treatment of breast cancer.

• Trastuzumab in the Adjuvant Treatment of Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
• Integrated Analysis of Zoledronic Acid for Prevention of Aromatase Inhibitor—Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole
• Commercialized Multigene Predictors of Clinical Outcome for Breast Cancer
• Use of i.v. Bisphosphonates in Older Women with Breast Cancer
• Targeted Therapies for the Treatment of Breast Cancer in the Post-trastuzumab Era
• Current Status of Prognostic Profiling in Breast Cancer
• Ixabepilone: A Novel Antineoplastic Agent with Low Susceptibility to Multiple Tumor Resistance Mechanisms
• Should Urogenital Atrophy in Breast Cancer Survivors Be Treated With Topical Estrogens?
• Prognostic Value of Initial Clinical Disease Stage After Achieving Pathological Complete Response
• First-Line Chemotherapy for HER-2–Negative Metastatic Breast Cancer Patients Who Received Anthracyclines as Adjuvant Treatment
• Current Treatment and Clinical Trial Developments for Ductal Carcinoma In Situ of the Breast
• Cardiovascular Reserve and Risk Profile of Postmenopausal Women After Chemoendocrine Therapy for Hormone Receptor–Positive Operable Breast Cancer
• How to Preserve Fertility in Young Women Exposed to Chemotherapy? The Role of GnRH Agonist Cotreatment in Addition to Cryopreservation of Embrya, Oocytes, or Ovaries
• Zoledronic Acid and Survival in Breast Cancer Patients with Bone Metastases and Elevated Markers of Osteoclast Activity
• First-Line Treatment Options for Patients with HER-2–Negative Metastatic Breast Cancer: The Impact of Modern Adjuvant Chemotherapy
• Some Aspects of the Endocrine Profile and Management of Hormone-Dependent Male Breast Cancer
• Lapatinib-Associated Toxicity and Practical Management Recommendations
• Development and Clinical Utility of a 21-Gene Recurrence Score Prognostic Assay in Patients with Early Breast Cancer Treated with Tamoxifen
• Sentinel Lymph Node Biopsy in Male Patients with Early Breast Cancer
• Pharmacodiagnostics and Targeted Therapies—A Rational Approach for Individualizing Medical Anticancer Therapy in Breast Cancer
• Capecitabine in Combination with Novel Targeted Agents in the Management of Metastatic Breast Cancer: Underlying Rationale and Results of Clinical Trials
• Steroid Sulfatase: A New Target for the Endocrine Therapy of Breast Cancer
• Targeting the Microtubules in Breast Cancer Beyond Taxanes: The Epothilones
• Achievements in Systemic Therapies in the Pregenomic Era in Metastatic Breast Cancer
• BRCA1, a Potential Predictive Biomarker in the Treatment of Breast Cancer
• Randomized, Double-Blind, Placebo-Controlled Crossover Trials of Venlafaxine for Hot Flashes After Breast Cancer
• Minimally Invasive Approaches for Diagnosis and Treatment of Early-Stage Breast Cancer
• Appraising Adjuvant Aromatase Inhibitor Therapy
• Molecular Classification of Breast Cancer: Limitations and Potential
• Adjuvant Therapy With Trastuzumab for HER-2/neu-Positive Breast Cancer
• Biologic Basis of Sequential and Combination Therapies for Hormone-Responsive Breast Cancer
• Adjuvant Hormonal Therapy in Peri- and Postmenopausal Breast Cancer
• Uses and Abuses of Tumor Markers in the Diagnosis, Monitoring, and Treatment of Primary and Metastatic Breast Cancer EXPIRED
• Primary Systemic Therapy of Breast Cancer EXPIRED
• Aromatase Inhibitors in Breast Cancer: An Overview EXPIRED
• Benign Breast Diseases: Classification, Diagnosis, and Management EXPIRED
• Fertility Preservation in Young Women Undergoing Breast Cancer Therapy EXPIRED
• Adjuvant Chemotherapy in the Elderly: Whom to Treat, What Regimen? EXPIRED
• Too Much, Too Little, Too Late to Start Again? Assessing the Efficacy of Bisphosphonates in Patients with Bone Metastases from Breast Cancer EXPIRED
• The Influence of Endocrine Effects of Adjuvant Therapy on Quality of Life Outcomes in Younger Breast Cancer Survivors EXPIRED
• Breast Cancer: Achievements in Adjuvant Systemic Therapies in the Pre-Genomic Era EXPIRED
• Extending Survival with Chemotherapy in Metastatic Breast Cancer EXPIRED
• Adjuvant Chemotherapy for Early Breast Cancer: Optimal Use of Epirubicin EXPIRED
• Controversies in the Therapy of Early-Stage Breast Cancer EXPIRED
• Can We Approach Zero Relapse in Breast Cancer? EXPIRED
• A Review of the Diagnosis and Management of Male Breast Cancer EXPIRED
• Population-Based Pharmacoeconomic Model for Adopting Capecitabine/Docetaxel Combination Treatment for Anthracycline-Pretreated Metastatic Breast Cancer EXPIRED
• Goals and Objectives in the Management of Metastatic Breast Cancer EXPIRED
• How Rapidly Do Oncologists Respond to Clinical Trial Data? EXPIRED
• Breast Cancer in African-American Women EXPIRED
• Facts and Controversies in Systemic Treatment of Metastatic Breast Cancer EXPIRED
• Ductal Lavage and Risk Assessment of Breast Cancer EXPIRED
• Prognostic and Predictive Factors in Early-Stage Breast Cancer EXPIRED
• What Is the Role of Ovarian Ablation in the Management of Primary and Metastatic Breast Cancer Today? EXPIRED
• Efficacy of First-Line Letrozole Versus Tamoxifen as a Function of Age in Postmenopausal Women with Advanced Breast Cancer EXPIRED
• Superiority of Letrozole to Tamoxifen in the First-Line Treatment of Advanced Breast Cancer: Evidence from Metastatic Subgroups and a Test of Functional Ability EXPIRED
• Carboplatin in Combination Therapy for Metastatic Breast Cancer EXPIRED
• Tamoxifen—What Next? EXPIRED
• Oncogenes and Tumor Suppressor Genes in Breast Cancer: Potential Diagnostic and Therapeutic Applications EXPIRED
• The Future of ErbB-1 and ErbB-2 Pathway Inhibition in Breast Cancer: Targeting Multiple Receptors (4 activities)
• The Role of Selective Estrogen Receptor Modulators in the Prevention of Breast Cancer: Comparison of the Clinical Trials EXPIRED
• Anemia in Stage II And III Breast Cancer Patients Treated With Adjuvant Doxorubicin and Cyclophosphamide Chemotherapy EXPIRED
• Update on Locally Advanced Breast Cancer EXPIRED
• Genetics and the Management of Women at High Risk for Breast Cancer EXPIRED
• Diagnosis and Management of Central Nervous System Metastases from Breast Cancer EXPIRED
• Liposomal Anthracyclines for Breast Cancer: Clinical Efficacy and Safety Update (Available Credits: 4) (4 activities)
• The HER-2/neu Gene and Protein in Breast Cancer 2003: Biomarker and Target of Therapy EXPIRED
• Advances in Endocrine Treatments for Postmenopausal Women with Metastatic and Early Breast Cancer EXPIRED
• Clinical Application of cDNA Microarrays in Oncology EXPIRED
• A Role for Curative Surgery in the Treatment of Selected Patients with Metastatic Breast Cancer EXPIRED
• Controversies Regarding the Use of Radiation After Mastectomy in Breast Cancer EXPIRED
• Incorporating Oral Capecitabine into the Treatment of Breast Cancer (1 activity)
• Phase II Trial of Weekly Vinorelbine and Trastuzumab as First-Line Therapy in Patients With HER2⁺ Metastatic Breast Cancer EXPIRED
• Preoperative Therapy in Breast Cancer: Lessons from the Treatment of Locally Advanced Disease EXPIRED
• Hormone Replacement in Women with a History of Breast Cancer EXPIRED
• Combination Endocrine Therapy in the Management of Breast Cancer EXPIRED
• Adjuvant Therapy for Breast Cancer: Recommendations for Management Based on Consensus Review and Recent Clinical Trials EXPIRED